Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study

Journal of the Neurological Sciences

Volumn 308, Issue 1-2, 2011, Pages 128-134

  Cappellari, Manuel ^a   Deluca, Cristina ^a,b   Tinazzi, Michele ^a,b   Tomelleri, Giampaolo ^a   Carletti, Monica ^c   Fiaschi, Antonio ^b   Bovi, Paolo ^a   Moretto, Giuseppe ^a  

^a Division of Neurology   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Cardiovascular and Thoracic Department   (Italy)

Author keywords

Acute ischemic stroke outcome; Statin; Thrombolysis

Indexed keywords

ATORVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051586179     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.05.026     Document Type: Article

References (32)

1. S.E. Lakhan, S. Bagchi, and M. Hofer Statins and clinical outcome of acute ischemic stroke: a systematic review Int Arch Med 3 2010 22
2. J. Montaner, Chacòn, J. Krupinski, F. Rubio, M. Millàn, and C.A. Molina Simvastatin in acute phase of ischemic stroke: a safety and efficacy pilot trial Eur J Neurol 15 2008 82 90
3. J. Àlvarez-Sabìn, R. Huertas, M. Quintana, P. Delgado, M. Ribo, and C.A. Molina Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator Stroke 38 2007 1076 1078
4. M. Blanco, F. Nombela, M. Castellanos, M. Rodriguez-Yáñez, M. García-Gil, and R. Leira Statin treatment withdrawal in ischemic stroke: a controlled randomized study Neurology 69 2007 904 910
5. M. Uyttenboogaart, M.W. Koch, K. Koopman, P.C. Vroomen, G.J. Luijckx, and J. De Keyser Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischemic stroke J Neurol 255 2008 875 880
6. N. Meier, K. Nedeltchev, C. Brekenfeld, A. Galimanis, U. Fischer, and O. Findling Prior statin use, intracranial hemorrhage and outcome after intra-arterial thrombolysis for acute ischemic stroke Stroke 40 2009 1729 1737
7. L. Zhang Multitargeted effects of statin-enhanced thrombolysis therapy for stroke with recombinant human tissue-type plasminogen activator in the rat Circulation 112 2005 3486 3494
8. N. Wahlgren, N. Ahmed, A. Dávalos, G.A. Ford, M. Grond, and W. Hacke SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study Lancet 27 369 2007 275 282
9. P. Amarenco, Bogousslavsky, A. Callahan III, L.B. Goldstein, M. Hennerici, and A.E. Rudolph Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 2006 549 559
10. V. Prinz, and M. Endres The acute (cerebro)vascular effects of statins Anesth Analg 109 2009 572 584
11. H.P. Adams, G. del Zoppo, M.J. Alberts, D.L. Bhatt, L. Brass, and A. Furlan Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Circulation 115 2007 e478 e534
12. T. Brott, H.P. Adams, C.P. Olinger, J.R. Marler, W.G. Barsan, and J. Biller Measurements of acute cerebral infarction: a clinical examination scale Stroke 20 1989 864 870
13. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41
14. M.G. Delgado, P. Michel, M. Naves, P. Maeder, M. Reichhart, and M. Wintermark Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population J Neurol Neurosurg Psychiatry 81 2010 282 285
15. M. Saqqur, G. Tsivgoulis, C.A. Molina, A.M. Demchuk, M. Siddiqui, and J. Àlvarez-Sabìn Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study Neurology 71 2008 1304 1312
16. T. Bourcier, and P. Libby HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells Arterioscler Thromb Vasc Biol 20 2000 556 562
17. C. Orem, H.A. Uydu, R. Yilmaz, M. Gökçe, M. Baykan, and S. Eminagaoglu The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients Jpn Heart J 45 2004 977 987
18. F. Wiesbauer, C. Kaun, G. Zorn, G. Maurer, K. Huber, and J. Wojta HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins Br J Pharmacol 135 2002 284 292
19. A. Notarbartolo, G. Davì, M. Averna, C.M. Barbagallo, A. Ganci, and C. Giammarresi Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia Arterioscler Thromb Vasc Biol 15 1995 247 251
20. J.W. Fenton Jr., and G.X. Shen Statins as cellular antithrombotics Haemostasis 29 1999 166 169
21. V. Sanguigni, P. Pignatelli, L. Lenti, D. Ferro, A. Bellia, and R. Carnevale Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients Circulation 111 2005 412 419
22. L. Szapary, B. Horvath, Z. Marton, T. Alexy, G. Kesmarky, and T. Habon Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia CNS Drugs 18 2004 165 172
23. G. Huhle, C. Abletshauser, N. Mayer, G. Weidinger, J. Harenberg, and D.L. Heene Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor Thromb Res 95 1999 229 234
24. B.A. Keyt, N.F. Paoni, C.J. Refino, L. Berleau, H. Nguyen, and A. Chow A faster-acting and more potent form of tissue plasminogen activator Proc Natl Acad Sci U S A 91 1994 3670 3674
25. K. Fassbender, C.-E. Dempfle, O. Mielke, A. Schwartz, M. Dattertshofer, and C. Eschenfelder Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator Stroke 30 1999 2101 2104
26. Y. Lampl, M. Lorberboym, R. Gilad, I. Vysberg, A. Tikozky, and M. Sadeh Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin Clin Neuropharmacol 33 2010 129 134
27. M. Moonis, K. Kane, U. Schwiderski, B.W. Sandage, and M. Fisher HMG-CoA reductase inhibitors improve acute ischemic stroke outcome Stroke 36 2005 1298 1300
28. L.T. Clark Treating dyslipidemia with statins: the risk-benefit profile Am Heart J 145 2003 387 396
29. R. Krysiak, B. Okopień, and Z. Herman Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes Drugs 63 2003 1821 1854
30. O.Y. Bang, J.L. Saver, D.S. Liebeskind, S. Starkman, P. Villablanca, and N. Salamon Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis Neurology 68 2007 737 742
31. M.G. Lansberg, G.W. Albers, and C.A. Wijman Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors Cerebrovasc Dis 24 2007 1 10
32. J. Diedler, N. Ahmed, M. Sykora, M. Uyttenboogaart, K. Overgaard, and G.J. Luijckx Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset Stroke 41 2010 288 294